Intra-Cellular Therapies Inc. buy Cantor Fitzgerald
Start price
24.04.24
/
50%
€68.50
Target price
24.04.25
€112.30
Performance (%)
-2.19%
Price
23.08.24
€67.00
Summary
This prediction is currently active. With a performance of -2.19%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 24.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | -2.899% | -2.899% |
iShares Core DAX® | 1.665% | 1.692% |
iShares Nasdaq 100 | -0.475% | 1.483% |
iShares Nikkei 225® | 2.620% | 4.475% |
iShares S&P 500 | -0.091% | 1.099% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $120.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
08.08.24
08.08.24
€119.16
08.08.25
08.08.25
-2.19%
23.08.24
23.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.50
14.06.24
14.06.24
€112.19
14.06.25
14.06.25
5.51%
23.08.24
23.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.80
23.02.24
23.02.24
€93.28
23.02.25
23.02.25
3.40%
23.08.24
23.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€59.40
14.12.23
14.12.23
€91.89
14.12.24
14.12.24
12.79%
23.08.24
23.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€51.30
03.11.23
03.11.23
€94.07
03.11.24
03.11.24
28.66%
23.08.24
23.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€80.23
29.03.24
29.03.24
22.14%
30.03.24
30.03.24